Beaudin, Marie http://orcid.org/0000-0001-8615-4390
Manto, Mario
Schmahmann, Jeremy D.
Pandolfo, Massimo
Dupre, Nicolas http://orcid.org/0000-0001-7270-6115
Article History
Accepted: 17 February 2022
First Online: 24 March 2022
Competing interests
: M.P. has received grants and personal fees from Biomarin, Minoryx and Voyager Therapeutics, and has received, grants from the European Commission — 7th Framework Programme, Fonds National de la Recherche Scientifique (Belgium) and the Friedreich’s Ataxia Research Alliance, and personal fees from Apopharma, Exicure, Design Therapeutics, Aavanti Bio, and UCB. He has a patent for methods to diagnose Friedreich ataxia (WO1997032996A1), royalties for which have been paid by Athena Diagnostics. None of these disclosures represent a conflict of interest that may be perceived as biasing the content of this manuscript. All other authors declare no competing interests.